During the past decade, Medizinische Universitatsklinik conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medizinische Universitatsklinik" #1 sponsor was "Bristol-Myers Squibb" with 5 trials, followed by "University of Ulm" with 3 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Forest Laboratories" with 1 trials sponsored and "Human Genome Sciences Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinische Universitatsklinik" #1 collaborator was "German Federal Ministry of Education and Research" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Medizinische Universitatsklinik" are "Acute Myeloid Leukemia (AML)" (3 trials), "Hepatitis C, Chronic" (2 trials), "Advanced Cancer" (1 trials), "Arrhythmia" (1 trials) and "Arthritis, Psoriatic" (1 trials). Many other conditions were trialed in "Medizinische Universitatsklinik" in a lesser frequency.

Most popular intervention types in "Medizinische Universitatsklinik" are "Drug" (9 trials), "Biological" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Cytarabine" (2 trials), "Methotrexate" (2 trials), "Nivolumab" (2 trials) and "Abatacept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medizinische Universitatsklinik" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Medizinische Universitatsklinik". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Medizinische Universitatsklinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medizinische Universitatsklinik, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".